IBT 9401
Alternative Names: Chondroitinase ACLatest Information Update: 29 Mar 2006
At a glance
- Originator BioMarin Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer metastases
Most Recent Events
- 29 Mar 2006 No development reported - Preclinical for Cancer metastases in Canada (unspecified route)
- 04 Dec 2003 This compound is still in active development
- 16 Jul 2001 New profile